Pillar · 12 min read

What is IoMT? The Internet of Medical Things, Explained

Summary

The Internet of Medical Things (IoMT) is the network of connected medical devices, sensors, and software that collect, transmit, and act on patient health data. It spans wearables on the wrist, monitors on the body, instruments at the bedside, and infusion and imaging systems in the hospital — all stitched together by gateways, cloud services, and the electronic health record.

The short definition

IoMT is the medical subset of the Internet of Things. Where consumer IoT connects thermostats and doorbells, IoMT connects pulse oximeters, continuous glucose monitors, smart inhalers, infusion pumps, hospital beds, and imaging equipment. The defining feature is not the device itself but the loop it closes: a sensor measures something about a patient, the measurement moves through a network, software interprets it, and a clinician — or, increasingly, an algorithm — acts on it.

How an IoMT system is put together

Most real IoMT deployments have four layers. Understanding them is the fastest way to make sense of vendor marketing.

  • Sensor layer. The device on or in the patient — wearable, patch, implant, bedside monitor. Captures vitals, motion, glucose, ECG, SpO2, temperature.
  • Gateway layer. A phone, hub, or bedside box that aggregates signals, handles short-range radios (Bluetooth LE, Zigbee), and forwards data upstream.
  • Platform layer. Cloud or on-premise services that store data, run analytics, raise alerts, and expose APIs to other systems.
  • Clinical layer. The EHR, the nurse’s dashboard, the on-call pager, and the workflows that turn data into decisions.

Where IoMT is actually used today

  • Remote patient monitoring (RPM). Post-sepsis syndrome surveillance, cardiac, COPD, post-surgical, and maternity programs that send patients home with connected devices instead of keeping them in a bed.
  • Chronic disease management. Continuous glucose monitors and smart insulin pens for diabetes; connected inhalers for asthma and COPD; connected blood pressure cuffs for hypertension.
  • Hospital-at-home. Acute-level care delivered in the patient’s residence, leaning heavily on IoMT for vitals capture and escalation.
  • In-hospital safety and efficiency. Smart infusion pumps, asset tracking, smart beds, and real-time location systems.
  • Clinical trials. Decentralised trials that use wearables and connected devices to capture endpoints without site visits.

The main device categories

For a deeper, opinionated look at specific products, see our companion piece on the top IoMT devices in 2026. At a category level, the landscape today breaks down into:

  • Continuous glucose monitors (Dexcom, Abbott Libre, Medtronic Guardian).
  • Cardiac monitors and implantable loop recorders.
  • Smart inhalers and connected respiratory devices.
  • Connected blood pressure and ECG devices (Omron, Withings, AliveCor).
  • Clinical-grade wearables and patches (BioIntelliSense, VitalConnect).
  • Smart infusion pumps and hospital-grade connected equipment.

Why IoMT security is its own discipline

A connected medical device is a computer that can hurt a patient. That single fact reorders every priority an IT team is used to: patching cannot interrupt therapy, downtime has a clinical cost, and the device’s ten-year lifespan does not match an operating system’s three-year support window. The result is a security problem with very specific shape — large fleets of long-lived devices, regulated change control, and an attacker population that ranges from opportunistic ransomware crews to nation-state actors.

We cover the central trade-off in detail in Interoperability vs. Security: Balancing the IoMT Paradox.

The regulatory backdrop

IoMT sits at the intersection of medical-device regulation (Health Canada under the Food and Drugs Act and SOR/98-282, the US FDA, and the EU MDR), health-data privacy (PIPEDA in Canada, HIPAA in the US, GDPR in the EU), and increasingly explicit cybersecurity requirements (Health Canada’s pre-market cybersecurity guidance, Section 524B of the US FD&C Act, and the EU Cyber Resilience Act). The practical effect is that manufacturers must ship a Software Bill of Materials, support a defined update lifecycle, and demonstrate a coordinated vulnerability disclosure process.

Where it’s heading

Three forces are reshaping the field. On-device AI is moving real clinical decisions to the phone and the patch. Biocompatible and ingestible sensors are opening measurement sites that wearables cannot reach. And the regulators have stopped treating cybersecurity as a post-market afterthought. The result is a category that looks less like “IoT for hospitals” and more like a distinct engineering discipline in its own right.

Keep reading